VON WILLEBRAND DISEASE (VWD)
Clinical trials for VON WILLEBRAND DISEASE (VWD) explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD) trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New clotting therapy shows promise for rare bleeding disorder
Disease control CompletedThis study tested a medication called rVWF (vonicog alfa) in 38 children and adults with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular treatment could reduce spontaneous bleeding episodes over 12 months. Participants received the drug for up t…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
UK study checks real-world use of new VWD treatment
Knowledge-focused CompletedThis study looked back at medical records of 34 adults with von Willebrand disease (VWD) in the UK who received vonicog alfa (a lab-made clotting protein) to treat bleeding or prevent bleeding during surgery. The goal was to see how the drug was used in routine care and how well …
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC